Once again, reduced tumor growth kinetics and metastatic incidence, as well as enhanced M1 macrophage marker expression, reduced M2 marker expression, and reduced T cell recruitment to the TME, suggesting a critical role of HGFL in the activation of RON signaling and its phenotypes likely for both tumor cell and macrophage RON signaling [3]. The gene discussed is MST1; the disease is neoplasm.